DHIYX
Price
$17.45
Change
+$0.08 (+0.46%)
Updated
Dec 20 closing price
VTMNX
Price
$15.31
Change
-$0.23 (-1.48%)
Updated
Dec 20 closing price
Ad is loading...

DHIYX vs VTMNX

Header iconDHIYX vs VTMNX Comparison
Open Charts DHIYX vs VTMNXBanner chart's image
Diamond Hill International Y
Price$17.45
Change+$0.08 (+0.46%)
VolumeN/A
CapitalizationN/A
Vanguard Developed Markets Index Instl
Price$15.31
Change-$0.23 (-1.48%)
VolumeN/A
CapitalizationN/A
DHIYX vs VTMNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DHIYX vs. VTMNX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHIYX is a StrongBuy and VTMNX is a Buy.

FUNDAMENTALS
Fundamentals
VTMNX has more cash in the bank: 198B vs. DHIYX (141M). VTMNX pays higher dividends than DHIYX: VTMNX (3.27) vs DHIYX (1.06). DHIYX was incepted earlier than VTMNX: DHIYX (5 years) vs VTMNX (24 years). DHIYX is a more actively managed with annual turnover of: 21.00 vs. VTMNX (3.00). DHIYX has a lower initial minimum investment than VTMNX: DHIYX (500000) vs VTMNX (5000000). DHIYX annual gain was more profitable for investors over the last year : 4.90 vs. VTMNX (1.11). DHIYX return over 5 years is better than : 24.65 vs. VTMNX (11.44).
DHIYXVTMNXDHIYX / VTMNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years24 years-
Gain YTD4.304-0.202-2,134%
Front LoadN/AN/A-
Min. Initial Investment500000500000010%
Min. Initial Investment IRAN/AN/A-
Net Assets141M198B0%
Annual Yield % from dividends1.063.2732%
Returns for 1 year4.901.11442%
Returns for 3 years9.06-3.41-265%
Returns for 5 years24.6511.44215%
Returns for 10 yearsN/A31.18-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTLB59.834.17
+7.49%
GitLab
MHH14.700.21
+1.45%
Mastech Digital
HLLY2.760.02
+0.73%
Holley
SPNT14.410.02
+0.14%
SiriusPoint Ltd
ZVSA1.14-0.10
-8.06%
ZyVersa Therapeutics